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ABSTRACT
Human mitochondrial transcription requires the
bacteriophage-related RNA polymerase, POLRMT,
the mtDNA-binding protein, h-mtTFA/TFAM, and
two transcription factors/rRNA methyltransferases,
h-mtTFB1 and h-mtTFB2. Here, we determined the
steady-state levels of these core transcription
components and examined the consequences of
purposeful elevation of h-mtTFB1 or h-mtTFB2
in HeLa cells. On a per molecule basis, we find an
»6-fold excess of POLRMT to mtDNA and »3-fold
more h-mtTFB2 than h-mtTFB1. We also estimate
h-mtTFA at »50 molecules/mtDNA, a ratio predicted
to support robust transcription, but not to coat
mtDNA. Consistent with a role for h-mtTFB2 in
transcription and transcription-primed replication,
increased mitochondrial DNA and transcripts
result from its over-expression. This is accompa-
nied by increased translation rates of most, but not
all mtDNA-encoded proteins. Over-expression of
h-mtTFB1 did not significantly influence these
parameters, but did result in increased mitochon-
drial biogenesis. Furthermore, h-mtTFB1 mRNA
and protein are elevated in response to h-mtTFB2
over-expression, suggesting the existence of a
retrograde signal to the nucleus to coordinately
regulate expression of these related factors.
Altogether, our results provide a framework for
understanding the regulation of human mitochon-
drial transcription in vivo and define distinct roles
for h-mtTFB1 and h-mtTFB2 in mitochondrial
biogenesis and gene expression that together
likely fine-tune mitochondrial function.
INTRODUCTION
Mitochondria are multifunctional organelles in eukaryotic
cells involved in numerous metabolic activities, the
production of ATP, and regulation of apoptosis.
Consistent with their bacterial ancestry and absolutely
critical for their function, is the mitochondrial DNA
(mtDNA) housed in the matrix of the organelle. In
humans, the 16569-bp circular mtDNA molecule contains
37 genes encoding thirteen essential integral membrane
proteins of the ATP-producing oxidative phosphorylation
(OXPHOS) system, two rRNA subunits of the mitochon-
drial ribosomes, and 22 tRNAs required for mitochon-
drial translation in the matrix. Therefore, the vast
majority of the  1500 proteins that localize and function
in mitochondria are not mtDNA-encoded, but rather are
products of nuclear genes that are imported into the
organelles. An important consequence of this arrangement
is that there must be coordination of nuclear and
mitochondrial gene expression in order to maintain
organelle homeostasis and to properly regulate mitochon-
drial activities. This is uniquely pertinent to the assembly
of the OXPHOS system and mitochondrial ribosomes,
which are composed of subunits encoded by both
the nuclear and mitochondrial genomes. That is, the
coordination of synthesis of subunits in mitochondria
(the 13 OXPHOS subunits and two rRNAs) with the
import of those from the cytoplasm (the  70 OXPHOS
subunits and  80 ribosomal proteins) is presumably
critical to regulate the biogenesis of these large complexes.
In this context, it is also important to consider that all of
the machinery required for transcription and replication
of mtDNA is a subset of the nucleus-encoded factors that
are targeted to mitochondria (1). How the relative
amounts and altered expression of these key regulatory
factors inﬂuence expression of mtDNA-encoded genes
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complexes and ribosomes is largely unknown.
The core protein components required for human
mitochondrial transcription have recently been deﬁned
as a mixed three-component system comprising a T-odd
bacteriophage-related mitochondrial RNA polymerase
(POLRMT), the high mobility-group-box mitochondrial
transcription factor A (h-mtTFA/TFAM), and two dual-
function transcription factors (h-mtTFB1/TFB1M and
h-mtTFB2/TFB2M) that are orthologs of an ancestral
bacterial rRNA methyltransferase (2–4). In terms of
transcription, POLRMT/h-mtTFB1 and POLRMT/
h-mtTFB2 complexes are each capable of initiation at
the mitochondrial L-strand promoter (LSP) and H-strand
promoter 1 (HSP1) in the presence of h-mtTFA, although
POLRMT/h-mtTFB2 complexes are reported to be
signiﬁcantly more active than POLRMT/h-mtTFB1
complexes in vitro (2). However, at speciﬁc h-mtTFA:
DNA ratios the activities of the two complexes are altered
to diﬀering degrees. This leaves open the likely possibility
that the rates of transcription in vivo can be dictated by the
relative concentrations of mtDNA and each of the
transcription components in diﬀerent cell types (1,5).
Estimates of h-mtTFA abundance in cells of human and
Xenopus have been reported by several groups, but with
conﬂicting results (6–9), and the relative or absolute
amounts of POLRMT, h-mtTFA, h-mtTFB1 and
h-mtTFB2 have not been systematically examined. Thus
a basic deﬁnition of the mitochondrial transcription
system in vivo is still lacking, a situation that limits our
understanding of how mitochondrial gene expression is
regulated.
As already mentioned, the recently identiﬁed h-mtTFB1
and h-mtTFB2 transcription factors are homologous to
rRNA methyltransferases. Speciﬁcally, they are related to
a large family of site-speciﬁc methyltransferases that
catalyzes the N6-dimethylation of two adjacent adenine
residues in a conserved stem-loop found in small subunit
rRNAs (10). In bacteria this modiﬁcation, while not
essential, inﬂuences both stability and ﬁdelity of ribo-
somes and is thought to modulate translational output
(11–13). In the original report describing h-mtTFB1, this
transcription factor was postulated to have rRNA
methyltransferase activity based on its ability to bind the
methyl-group donating co-factor s-adenosylmethionine
(3). Subsequent work showed that both h-mtTFB1 and
h-mtTFB2 can functionally replace the homologous KsgA
dimethyltransferase in Escherichia coli (5,14), demonstrat-
ing that both proteins have retained this enzymatic
activity. Interestingly, in this assay, h-mtTFB2 has
signiﬁcantly lower activity than h-mtTFB1 (5). This,
coupled to their diﬀering relative activity with regard to
transcription output and the concentration of h-mtTFA,
again suggests a potentially interesting regulatory scenario
in which diﬀerential eﬀects on mitochondrial transcription
and ribosome biogenesis/function (via diﬀerential rRNA
methylation) are mediated by the relative abundance or
activity of h-mtTFB1 and h-mtTFB2 (1,5). Interestingly,
other functions for members of this class of rRNA
methyltransferases have been assigned that are indepen-
dent of the catalytic activity. For example, the yeast
Dim1p cytoplasmic rRNA methyltransferase plays a role
in rRNA processing (15,16). Likewise, we have shown that
the transcription factor activity of h-mtTFB1 is unaﬀected
by mutations that inactivate its rRNA methyltransferase
activity (17). Thus, whether h-mtTFB1 and h-mtTFB2
have additional roles beyond transcription and rRNA
methylation remains a formal possibility.
To date, the only studies regarding the function of
metazoan mtTFB transcription factors in vivo were
performed on the Drosophila proteins using cultured
Schneider cells. Consistent with a role for dm-mtTFB2
in transcription and transcription-primed mtDNA repli-
cation, RNAi knock-down or over-expression results in
decreased or increased steady-state levels of mitochondrial
RNA and mtDNA, respectively (18). In contrast, no eﬀect
on mtDNA copy number or the steady-state levels of
mitochondrial transcripts is observed when expression of
dm-mtTFB1 is knocked down or over-expressed in this
system (19). However, RNAi knock-down of dm-mtTFB1
does result in a reduction in the rate of mitochondrial
protein synthesis, indicating a role for this protein in
regulating mitochondrial translation (perhaps via its
rRNA methyltransferase activity) (19). These results
demonstrate that the functions of dm-mtTFB1 and
dm-mtTFB2 are not fully redundant in vivo and suggest
that the primary role of dm-mtTFB2 is to regulate
transcription and/or mtDNA copy number and that of
dm-mtTFB1 is to modulate translation. However, it is
important to note that these studies do not discount the
possibility of partially overlapping functions for each
factor in transcription and rRNA methylation that one
might predict based on the fact that both h-mtTFB1 and
h-mtTFB2 have retained both of these activities over the
course of evolution (5). Furthermore, given the signiﬁcant
diﬀerences between mammals and ﬂies in general and with
regard to mitochondrial genome organization and
dynamics (20–22), it is important not to generalize any
relationships described in this (or any other) model system
without direct conﬁrmation in human cells. Here, we
describe our analysis of the human mitochondrial
transcription system in HeLa cells that deﬁnes the relative
steady-state levels of the entire human mitochondrial
transcription machinery for the ﬁrst time and elucidates
novel properties and functions of h-mtTFB1 and
h-mtTFB2 in vivo via their purposeful over-expression.
MATERIALS AND METHODS
Plasmids forbacterial and human cell expression of
h-mtTFB1 andh-mtTFB2
Bacterial expression vectors for production of h-mtTFB1
and h-mtTFB2 in E. coli were created using pET21b
(Promega). The h-mtTFB1 and h-mtTFB2 cDNAs were
ampliﬁed using primers 50-AACATATGGCTGCCTCC
GG-30 and 50-AAGAGCTCGAGTCTGTAATTCTC-30
or primers 50-AACATATGTGGATCCCAGTGG-30 and
50-GCGGCCGCCCTATCTTCCAGGGTTC-30, respec-
tively, and the resulting PCR products were ligated into
pGEMT-Easy (Promega). These plasmids were then
digested with appropriate restriction enzymes for ligation
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NotI for h-mtTFB2). To generate plasmids for over-
expression in human cells, the h-mtTFB1 and h-mtTFB2
cDNAs were both cut from previously described vectors
(5) using EcoRV and NotI and ligated into pcDNA3.1 zeo
(+) (Invitrogen) cut with the same enzymes. The vector
used to express POLRMT in bacteria was pProEX-Htb
(Invitrogen). A portion of the human cDNA encoding
amino acids 41–1250 and the stop codon was cloned into
the BamH1 and XhoI of this vector via a BamH1–Sal1
restriction fragment. Amino acids 1–40 were deleted since
they compose the mitochondrial localization sequence
(MLS) that is predicted to be removed by proteases during
import into mitochondria (23). However, in place of the
MLS, there are 29 unnatural amino acids fused to
POLRMT that include a initiator methionine, a His6
tag, a spacer of seven amino acids, a TEV protease
cleavage site, and another spacer of six amino acids. The
vector has an intact E. coli lacI
q gene allowing POLRMT
expression from the trc promoter to be regulated by
addition of isopropylthiogalactoside (IPTG; Sigma).
Purification of recombinant proteins
BL21-Codonplus E. coli (Stratagene) were transformed
with pET21b vectors containing either h-mtTFB1 or
h-mtTFB2. For puriﬁcation of h-mtTFB1, an overnight
culture of bacteria was diluted into 1l of LB media and
grown at 378C until culture reached an OD600 of 0.8.
IPTG was added to 1mM for induction of expression and
the culture was allowed to incubate at room temperature
with shaking for 24h. Cells were harvested by centrifuga-
tion, then pellets were resuspended in 80ml of lysis buﬀer
(50mM sodium phosphate, pH 8.0; 0.3M NaCl, 10%
glycerol, 0.1% Tween-20 and 10mM imidazole). Cells
were lysed by sonication and the suspension was cleared
by centrifugation. The clariﬁed lysate was applied to a
BD-Talon column (BD Biosciences). The column was
washed with 10 column volumes of lysis buﬀer and eluted
with three column volumes of lysis buﬀer plus 150mM
imidazole. Fractions were assayed for presence of mtTFB1
by SDS-PAGE followed by either coomassie staining or
western blot. Peak fractions were combined, concentrated
and dialyzed into storage buﬀer (20mM Tris-HCl, pH 8.0;
0.5mM EDTA, 0.25M sucrose, 15% glycerol, 1mM DTT
and 1mM PMSF). Protein concentration was determined
with a protein assay kit from Bio-Rad and conﬁrmed by
SDS-PAGE and coomassie staining with comparison
against a BSA standard curve. For puriﬁcation of
h-mtTFB2, the same procedure was followed for
mtTFB1, except that the protein was found to be highly
insoluble and present in the pellet after sonication. Pellets
after sonication were resuspended in lysis buﬀer with the
addition of 0.1% Triton, 5mM BME, 1mM PMSF and
6M guanidine-HCl. The solution was stirred overnight at
48C then clariﬁed by centrifugation. The protein solution
was added to a Talon column as before, then washed
with 10 column volumes of the pellet resuspension buﬀer.
The column was eluted with three column volumes of the
same buﬀer plus 200mM imidazole. Fractions were
analyzed as above and peak fractions were collected.
Concentrated samples were dialyzed extensively against
storage buﬀer and protein concentration was determined.
Puriﬁcation of h-mtTFA was performed as described (24),
except the process was stopped after the BioRex-70
column (Bio-Rad). The expression and puriﬁcation of
POLRMT was performed as described (25).
HeLa cell growth and transfection
For transfection of HeLa cells (Clonetech) with h-mtTFB1
or h-mtTFB2 over-expression plasmids, cell were seeded
at 5 10
5 per 10cm dish in DMEM (Sigma) plus 10%
Bovine Growth Serum (Hyclone) and allowed to grow
for 24h. Cells were transfected with empty pcDNA3.1
vector, pcDNA3.1-mtTFB1 or pcDNA3.1-mtTFB2 using
Eﬀectene (Qiagen) according to manufacturer’s sugges-
tions. Cells were allowed to incubate with plasmid/reagent
complexes for 24h. Transfected cells were subcultured by
diluting cells 1:50 or 1:100 in growth media with 400mg/ml
Zeocin (Invitrogen) and plated in 10cm dishes. Cells were
grown until individual colonies were visualized and 10–15
clones were individually selected with glass cylinders and
transferred to 24-well plates. Cells were grown to
conﬂuence, subcultured into 6-cm dishes in growth
media plus 100mg/ml Zeocin and grown for 48h. One
dish for each clone was harvested and assayed for protein
expression via western blot. Remaining plates were
harvested and stored in growth media plus 10% DMSO
at  808C. Stably transfected HeLa lines were consistently
plated at 5000 cells/cm
2, grown for 72h at 378C and 5%
CO2 before subculturing again. All experiments were
performed on cells passaged at most 10 times.
Antibody production and western analysis of whole-cell and
mitochondrial proteins
Four polyclonal peptide antibodies (two for h-mtTFB1
and two for h-mtTFB2) were generated for us by Multiple
Peptide Systems. The peptides used as antigens were as
follows: TFB1-1 H-CVPKPEVDVGVVHFTPLIQPKIE-
NH2, TFB1-2 H-CREELKRRKSKNEEKEEDDAEN
YRL-NH2, TFB2-1 H-CWIPVVGLPRRLRLSALAGA-
NH2, TFB2-2 H-CPQLWPEPDFRNPPRKASKASLD-
NH2. Multiple Peptide Systems performed the synthesis of
peptides, injection of rabbits and collection of serum, and
also provided a small batch of peptide-aﬃnity puriﬁed
antibody. We also used antibodies that were puriﬁed from
provided crude serum using protein-A sepharose
(Amersham). Speciﬁcity of each antibody was determined
by immunoblots of 200ng of recombinant full-length
h-mtTF1 and h-mtTFB2 proteins run alongside one
another on the same gel. Antiserum used to detect
human POLRMT was the same as that described
previously (26) and polyclonal antibodies for detection
of h-mtTFA were generously provided by Dr David
Clayton.
For whole-cell extracts, 1 10
6 cells were suspended in
100ml of cold lysis buﬀer (50mM Tris-HCl pH 8.8,
150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS, 2mM EDTA, 10% glycerol, 5mM DTT,
1mM PMSF) and incubated at 48C with rotation for
30min. Protein concentration was determined using the
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protein were loaded on polyacrylamide gels for analysis.
For mitochondrial extracts, mitochondria were harvested
by diﬀerential centrifugation. Brieﬂy, cells were resus-
pended in 10 pellet volumes of RSB buﬀer (10mM NaCl,
1.5mM MgCl2, 10mM Tris-HCl pH 7.5), swelled on ice
for 10min, homogenized with a motorized Teﬂon pestle,
then 2.5 MS Buﬀer (525mM mannitol, 175mM sucrose,
125mM Tris-HCl pH 7.5, 2.5mM EDTA) was added to
1 . The homogenate was centrifuged at 980g for 10min
twice to pellet nuclei and unbroken cells. The supernatant
was transferred to a fresh tube and spun at 17000g for
30min to pellet mitochondria. The mitochondrial pellet
was washed three times with 1 MS buﬀer then stored at
 808C until further use. Mitochondrial pellets were
resuspended in lysis buﬀer equal to one volume of the
original cell pellet. The protein extract was then treated
and quantiﬁed as described above.
Protein extracts were separated on SDS–polyacrylamide
gels and then transferred to PVDF membranes.
Membranes were blocked with 5% milk/TBST (10mM
Tris-HCl pH 8.0, 150mM NaCl, 0.05% Tween-20) for
30min at room temperature, then probed with primary
antibody in 5% milk/TBST overnight at 48C. The primary
antibody was removed and the blot was washed three
times for 10min with TBST. The appropriate secondary
antibody was applied in 5% milk/TBST and allowed to
incubate at room temperature for 1h. The blot was
washed again, ECL reagent was added and blots were
exposed to ﬁlm. Several exposures were obtained, then
ﬁlms were photographed and analyzed with a BioRad
VersaDoc and Quantity One software (v4.6.1). For serial
western blots, membranes were stripped with stripping
buﬀer (65mM Tris-HCl pH 6.8, 2% SDS, 100mM BME)
at 508C for 30min, then reblocked with 5% milk/TBST.
Determination of therelative steady-state levelsof the
human mitochondrial transcription proteins
Mitochondria were harvested as described above but
were puriﬁed additionally by centrifugation through
a 1.0–1.5M sucrose step gradient at 45000r.p.m. in
a SW50.1 rotor for 2h. Mitochondria were removed from
the interface of the two sucrose solutions by pipetting and
transferred to a fresh tube. Mitochondria were washed
with 1ml of 1 MS Buﬀer and pelleted by centrifugation
at 13000r.p.m. for 10min. The ﬁnal pellet was stored at
 808C until further use. Eﬃciency of mitochondrial
harvest was measured by amount of HSP60 and
h-mtTFA immunoblot signal obtained from fractions
reserved throughout the process and compared to
amounts from starting whole-cell lysates. Final mitochon-
drial pellets were lysed, extracts were quantiﬁed as
described above, and samples ranging from 10 to 100mg
of total mitochondrial protein were separated alongside
50–150mg of whole-cell lysate and a range of amounts
of puriﬁed recombinant proteins (1–100ng) on 6–20%
SDS–polyacrylamide gradient gels. Proteins were trans-
ferred to PVDF and western blotting was performed as
described above. A standard curve was generated from
signal obtained from recombinant proteins and used to
determine the amount of the respective protein in each of
the sample lanes.
Nucleic acidextraction, northernblotting, reverse
transcriptase real-time PCR and mtDNA copy
numberanalysis
Cells were harvested after 72h of growth in conditions
described above and counted. For each cell line, 1 10
6
cells were used for RNA extraction using the RNEasy Kit
(Qiagen) according to included instructions. During the
process, DNA was digested with RNAse-free DNAse
according to manufacturer’s suggestions. RNA was eluted
in the ﬁnal step using dH2O, quantiﬁed and stored at
 808C until further use. Gel electrophoresis, blotting of
RNA and probing of blots with 16S, 12S, ND2 and ND6
probes were performed as previously described (25).
For analysis of h-mtTFB1 transcript levels, ﬁrst strand
cDNA synthesis was performed by combining 2mg of total
RNA with 1mM dNTPs and 8mM oligodT15 in a 20ml
reaction volume. This mixture was heated to 708C for
10min then allowed to cool to 48C over 10min to anneal
the oligodT primer to polyA tails of mRNAs. An equal
volume of reverse transcriptase mix [200 units M-MuLV
Reverse Transcriptase (NEB), 2X M-MuLV RT Buﬀer
and 25 units of RNAseOUT (Invitrogen)] was added to
each primer-RNA mix and incubated at 428C for 1h.
The reactions were then heated to 708C for 10min to
deactivate the reverse transcriptase. Finally, an equal
volume of 3mM Tris-HCl pH 8.5, 0.3mM EDTA was
added to each reaction and samples were stored at  208C
until further use. Samples of each cDNA were thawed and
diluted from 16- to 32-fold in dH2O. 10mlo fad i l u t e d
cDNA sample was added to 14mlo fS Y B RG r e e nr e a c t i o n
mix (27) to each well along with 0.5ml of both appropriate
25mM primers. b-Actin primers, b-actin RT F 50 TGG
CACCACACCTTCTACAATGAGC 30 and b-actin RT
R5 0 GCACAGCTTCTCCTTAATGTCACGC 30, were
used as controls for total cDNA in each reaction. To
amplify the h-mtTFB1 transcript, primers TFB1 RT-F
50 TCTGCAATGTTCGACACATC 30 and TFB1 RT-R
50 ACCTATATAAGAAGCTCCAC 30 were used.
Reaction conditions for the BioRad iCycler were as
follows: 958C, 10min, 1 cycle; 958C, 30s, 568C, 30s,
728C, 30s, 40 cycles. Fluorescence was measured after
each 568C step. Melt-curve analysis to ensure single
products was performed immediately after completion of
steps above by using a temperature step gradient from
55 to 808C in 0.58C increments with ﬂuorescence measured
after a 10s incubation at each temperature. Ct values for
each reaction were obtained through the iCycler iQ
software. h-mtTFB1 transcript levels were then normal-
ized by b-actin transcript levels and compared to empty
vector controls.
Total DNA was extracted from 1 10
6 cells by addition
of 500ml of extraction buﬀer (50mM Tris-HCl pH 8.5,
0.25% SDS, 1mM EDTA, 5mM DTT) and boiling for
10min. After cell lysis, tubes were allowed to cool to room
temperature, 100mg of RNAse A were added, and tubes
were allowed to incubate at 378C. Following a 3h
incubation, 100mg of proteinase K were added and
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heated to 958C for 5min and allowed to cool to room
temperature. Total DNA concentration was measured and
samples were stored at -208C until further use.
Relative and absolute mtDNA copy numbers were
measured by SYBR Green ﬂuorescence using a BioRad
iCycler and accompanying software (v3.1). Total DNA
samples were diluted to a range of DNA concentrations
from 500 to 7.8pg/ml and 10ml were dispensed to
appropriate wells of a 96-well PCR plate. 14ml of SYBR
Green reaction mix (27) were added to each well along
with 0.5ml of both appropriate 25mM primers. For
detecting relative levels of mtDNA, a region of the
mitochondrial genome encompassing a portion of COX3
and a region of the multicopy nuclear 18S rDNA locus
were used. Primers are as follows: RTQ COX3-F
50 CACCCAAGAACAGGGTTTGT30, RTQ COX3-R
50 TGGCCATGGGTATGTTGTTAA 30, RTQ 18S F
50TAGAGGGACAAGTGGCGTTC30 and RTG 18S R
50CGCTGAGCCAGTCAGTGT30. Reaction conditions
for the iCycler were as follows: 958C, 10min, 1 cycle;
958C, 15s, 608C, 1min, 40 cycles. Fluorescence was
measured after each 608C step. Melt-curve analysis to
ensure single products was performed immediately after
completion of steps above by using a temperature step
gradient from 55 to 808C in 0.58C increments with
ﬂuorescence measured after a 10s incubation at each
temperature. Standard curves to determine absolute copy
number were constructed with known amounts (1638400
to 100 templates) of the plasmid pGEMT Easy (Promega)
containing either one of the PCR products obtained using
the mitochondrial and nuclear primers described above
(COX3 or 18S).
Labelingof mitochondrial translation products invivo
Labeling was performed as described (28) with modiﬁca-
tions. HeLa cells were seeded and grown as described
above in 10cm dishes. After 72h of growth, cells were
washed three times with 5ml of sulfur-free media (Gibco)
without serum. Cells were allowed to incubate for 5min at
378C, 5% CO2 before removing media. After the last
wash, 5ml of sulfur-free media with 10% BGS plus
100mg/ml emetine were added to each plate and allowed
to incubate at 378C, 5% CO2 for 5min. After this
incubation step, Expre
35S
35S Protein Labeling Mix
(Perkin Elmer) was added to each plate to a concentration
of 125mCi/ml and labeling was allowed to proceed at 378C
and 5% CO2. After 1h, the labeling media was removed
and the plates were rinsed once with 5ml of normal
DMEM with 10% BGS. Plates were then washed twice
with 10ml of TD buﬀer (25mM Tris pH 7.5, 137mM
NaCl, 10mM KCl, 0.7mM Na2HPO4), trypsinized and
harvested by centrifugation at 1000g. Cell pellets were
washed once with 10ml of TD buﬀer, then transferred to a
1.5ml tube with 1ml of TD buﬀer and harvested again
by centrifugation. Mitochondria were harvested as above
and protein was quantiﬁed. 50mg of total protein
were added to each lane of a 10–20% linear gradient
SDS–polyacrylamide gel. Samples were separated and
then the gel was dried and exposed to ﬁlm at  808C.
Kasugamycin sensitivity assays
HeLa cells were plated and grown as described above.
After 48h of growth, kasugamycin was added at indicated
concentrations and cells were allowed to incubate for 72h.
Cells were washed, trypsinized and treated with 0.08%
Trypan Blue in PBS. The total number of viable cells at
each drug concentration was compared to that of zero-
drug controls to yield a percentage of viable cells that is
plotted as a function of the drug concentration.
FACS analysis
HeLa cultures were plated and grown as described above.
After 72h of growth, cells were stained in culture media
with 70nM Mitotracker Green and 90nM Mitotracker
Red CMXRos, both from Molecular Probes, for 30min at
378C, 5% CO2. After staining, dyes were removed and
cells were washed three times with PBS. Cells were
trypsinized and collected by centrifugation. Cell pellets
were resuspended in 1ml of PBS and analyzed on a BD
FACS calibur instrument with accompanying software.
Histograms and means for these data were obtained using
FlowJo (v 8.0.1)
Mitochondrial localization sequence andcleavage prediction
Full-length sequences of h-mtTFB1, h-mtTFB1 and
sc-mtTFB were obtained from NCBI. These sequences
were submitted to cleavage site prediction by the SignalP
program (v3.0, http://www.cbs.dtu.dk/services/SignalP/)
(29). Hidden Markov modeling option was selected and
the ﬁrst 70 amino acids for each sequence were used for
signal and cleavage site prediction (30).
RESULTS
Relative levels ofthe human mitochondrial transcription
machinery in HeLa cells
To fully understand any transcription system, a critical
parameter to know is the relative amounts of the basal
transcription machinery in vivo. Our approach was to use
immunoblotting to establish the levels of the mitochon-
drial transcription machinery on a total cell and mitochon-
drial basis. This method requires antibodies that are speciﬁc
for their target, especially for homologous proteins that
are very similar in size. Since h-mtTFB1 and h-mtTFB2
share a large degree of sequence similarity and are
predicted to migrate similarly on polyacrylamide gels, it
was unclear if antibodies we had generated would cross
react with the paralogous protein and confound our
analysis. Therefore, we ﬁrst generated peptide antibodies
against h-mtTFB1 and h-mtTFB2 (see Materials and
Methods section) and determined their speciﬁcity by
assessing reactivity toward puriﬁed full-length recombi-
nant h-mtTFB1 and h-mtTFB2 by immunoblotting. We
found that these antibodies were indeed highly speciﬁc
for their targets showing no reactivity with the paralogous
protein (Figure 1A). Having antibodies capable of
speciﬁcally detecting each of the four human mitochon-
drial transcription proteins, as well as known amounts
of corresponding recombinant proteins, allowed us to
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puriﬁed mitochondria from logarithmically growing HeLa
cells and performed quantitative western blot analysis of
POLRMT, h-mtTFA, h-mtTFB1 and h-mtTFB2 on
known amounts of total mitochondrial protein. For each
protein analyzed, multiple dilutions of total mitochondrial
protein or total whole-cell lysate were probed in parallel
with a dilution series of known amounts of recombinant
protein to allow the amount of each transcription
component relative to the total amount of mitochondrial
lysate to be determined. Representative western blots and
standard curves showing linearity of the assays employed
are shown in Supplementary Figure S1.
Based on this analysis, we calculated the following
amounts of each transcription component/100mg of total
mitochondrial protein: 45.8 9.7ng of h-mtTFA,
4.03 .20ng of h-mtTFB1, 14.9 .97ng of h-mtTFB2
and 32.3 2.1ng of POLRMT. For whole-cell lysates, we
were only able to accurately measure h-mtTFA levels and
found 11.1 2.4fg of protein per cell (data not shown).
Next, we determined the number of molecules/cell based
on the amount of total mitochondrial protein isolated
from 4.5 10
7 cells. We found there to be 25.2 2.51pg
of mitochondrial protein per cell with recoveries of
75–80% of total mitochondria for three separate experi-
ments based on HSP60 and h-mtTFA immunoblots
(data not shown). These measurements result in
2.52 10
5, 1.35 10
4, 4.29 10
4 and 3.12 10
4 molecules
per cell for h-mtTFA, h-mtTFB1, h-mtTFB2 and
POLRMT, respectively (Table 1). This amount of
h-mtTFA from mitochondrial samples agreed well with
our measurement in whole-cell lysates at 2.78 10
5
molecules per cell (data not shown). Finally, we
also determined the mtDNA copy number in the cells
to be 5010 386 using quantitative real-time PCR
(Supplementary Figure S2). From these data, we calcu-
lated the relative levels of the four transcription proteins
on a molecule/cell basis and as function of the number of
mtDNA molecules/cell (Table 1). Interestingly, there is
 3-fold more h-mtTFB2 than h-mtTFB1 in these cells,
which results in a close to 1:1 relationship between
h-mtTFB2 and POLRMT (1.37:1), but an excess of
POLRMT to h-mtTFB1 (2.31:1). Furthermore, our
measurements place POLRMT at an  6-fold molar
excess over the number of mtDNA molecules and between
42 and 58h-mtTFA molecules/mtDNA molecule in HeLa
cells. Our h-mtTFA to mtDNA ratio is consistent with
that observed by Wiesner and colleagues (8), but more
than 30-fold lower than that proposed by Kang and
colleagues (7).
h-mtTFB2 iscleaved upon import and its over-expression
results inan increase in h-mtTFB1 levels
With a determination of relative levels of the mitochon-
drial transcription machinery in hand, we next set out to
examine the consequence of altering the relative amounts
of these proteins on mitochondrial gene expression and to
determine if their expression levels are coordinately
regulated. To do this, we created stable HeLa cell lines
that over-express either h-mtTFB1 or h-mtTFB2. From
Figure 1. h-mtTFB2 is processed in vivo and its over-expression in
HeLa cells results in a coordinated increase of h-mtTFB1, but not
POLRMT or h-mtTFA. (A) Shown are western blots on 200ng of
recombinant h-mtTFB1 and h-mtTFB2 proteins probed with four
peptide antibodies: TFB1-1, TFB1-2, TFB2-1 and TFB2-2.
Antibodies were found to speciﬁcally recognize their full-length
recombinant peptide and not cross react with the paralogous
protein. Coomassie staining of full-length recombinant h-mtTFB1
and h-mtTFB2 (top panel) demonstrates loading and their diﬀerence
in molecular weight. (B) Western blot of mitochondrial extracts
(100mg protein) from HeLa cell lines over-expressing h-mtTFB1
or h-mtTFB2 used in this study in parallel with recombinant
h-mtTFB1 and h-mtTFB2 run as controls. The blot was probed
as indicated using peptide antibodies that distinguish h-mtTFB1 and
h-mtTFB2 (a-h-mtTFB1 and a-h-mtTFB2) and an antibody that
recognizes HSP60 (a-HSP60) that was used as a mitochondrial
loading control. The lanes are loaded as follows: lane 1, molecular
weight markers; lane 2, recombinant h-mtTFB1; lanes 3, recombi-
nant h-mtTFB2; lanes 4–8, mitochondrial extracts from an empty
pcDNA 3.1 zeo (+) vector-control, h-mtTFB1 over-expression, and
three diﬀerent h-mtTFB2 stable over-expression HeLa cell lines,
respectively. (C) Shown are the results of real-time RT-PCR
measurement of h-mtTFB1 mRNA (see Supplementary Figure S3)
in h-mtTFB1 and h-mtTFB2 over-expression cell lines relative to
empty-vector control cells. Reverse transcriptase real-time PCR was
used to measure Ct values for cDNA samples from listed cell lines.
The Ct values for h-mtTFB1 mRNA were normalized to those of
b-actin and the values shown were normalized to the ratio obtained
in the empty-vector control, which was given a value of 1. Values
shown are the mean SD for three separate measurements. (D)
Western blot of mitochondrial lysates from the same cell lines
described in B probed using antibodies that recognize h-mtTFA (a-
h-mtTFA), POLRMT (a-POLRMT), and the outer mitochondrial
membrane protein VDAC (a-VDAC/porin) as a mitochondrial
loading control.
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two novel observations. First, the mobility of h-mtTFB2
isolated from cells was signiﬁcantly faster than that of the
corresponding recombinant protein (Figure 1B). Since
many matrix-localized mitochondrial proteins have an
N-terminal localization sequence (MLS) that is often
removed by proteases upon import, we hypothesized that
this was the case for h-mtTFB2. Consistent with this,
using SignalP (a MLS and cleavage site prediction
program), a single high-probability mitochondrial pepti-
dase cleavage site for h-mtTFB2 was found between
amino acids 30 and 31 (data not shown). No such cleavage
site was predicted for h-mtTFB1, consistent with no
obvious change in mobility of this protein relative to its
recombinant control (Figure 1B). Furthermore, mapping
amino acids 5–22 onto a helical-wheel diagram reveals
a pattern consistent with a putative amphipathic helix
(data not shown), which is another common attribute of
an MLS. Finally, using a peptide antibody (TFB2-1) that
was made against amino acids 2–20 of h-mtTFB2 (which
are predicted to be removed by SignalP), we were unable
to successfully detect endogenous h-mtTFB2 by western
blotting (data not shown). However using the peptide
antibody (TFB2-2) generated against amino acids 49–70,
which is used throughout this study, we readily detect
endogenous h-mtTFB2 (Figure 1B). Taken together, these
data suggest that amino acids 1–30 likely comprise a
signiﬁcant portion of the MLS for h-mtTFB2 and are
removed upon import.
In addition to the increased mobility of h-mtTFB2
described above, we also found that in the cell lines that
over-express h-mtTFB2, there was a corresponding
increase in the steady-state level of h-mtTFB1
(Figure 1B, compare lanes 6, 7 and 8 to lane 4).
However, the converse was not true. That is, there was
no increase in h-mtTFB2 steady-state levels when
h-mtTFB1 was over-expressed  10-fold (Figure 1B,
compare lane 5 to lane 4). We also analyzed the steady-
state levels of the remaining transcription machinery in
the face of h-mtTFB1 or h-mtTFB2 over-expression.
No obvious changes in the amounts of POLRMT or
h-mtTFA per mitochondrion were observed in either case
(Figure 1D).
To begin to determine the mechanism of increased
h-mtTFB1 levels due to h-mtTFB2 over-expression we
employed reverse transcriptase real-time PCR to measure
the steady-state amounts of h-mtTFB1 mRNA. In
the h-mtTFB2 over-expression cell lines, h-mtTFB1
mRNA was increased  2.5-fold (Figure 1C and
Supplementary Figure S3), in good correspondence with
the observed increase in h-mtTFB1 protein levels
(Figure 1B). As expected there was a large ( 64-fold)
increase in h-mtTFB1 mRNA in the h-mtTFB1 over-
expression lines (Figure 1C). However, this did not
correspond with the only  10-fold over-expression of
the protein (Figure 1B), suggesting that post-transcrip-
tional mechanisms may limit h-mtTFB1 expression or
accumulation.
Over-expression of h-mtTFB2, but noth-mtTFB1, increases
the steady-state levelsof mtDNA-encoded transcripts,
OXPHOS subunits and mtDNA and enhances therate of
mitochondrial translation
To address how altered levels of h-mtTFB1 and
h-mtTFB2 aﬀect mitochondrial gene expression, we next
examined the h-mtTFB1 and h-mtTFB2 over-expression
HeLa cell lines for changes in the steady-state levels
of mtDNA-encoded transcripts and proteins, as well as
for alterations in mtDNA copy number. Northern
analysis of the mitochondrial 16S and 12S rRNAs and
of ND2 and ND6 transcripts (representing mRNAs
transcribed from each strand of mtDNA) revealed a
 2-fold increase in their steady-state levels in the
h-mtTFB2 over-expression cell line, but no change in the
h-mtTFB1 over-expression line (Figure 2A). Similar
results were obtained when immunoblots of the
mtDNA-encoded COX1 and COX2 proteins was per-
formed and mtDNA copy number was measured. That is,
over-expression of h-mtTFB2, but not h-mtTFB1, led to a
signiﬁcant increase in the steady-state levels of COX1 and
COX2 proteins (Figure 2B) and a doubling of the
mtDNA copy number (Figure 2C). Altogether, these
results are consistent with a role for h-mtTFB2 in
transcription and in transcription-primed mtDNA repli-
cation. However, the fact that h-mtTFB1 is up-regulated
in the h-mtTFB2 over-expression lines makes it diﬃcult to
assign these functions to h-mtTFB2 acting independently
of h-mtTFB1.
Both h-mtTFB1 and h-mtTFB2 have retained rRNA
methyltransferase activity that is postulated to modulate
mitochondrial ribosome biogenesis and/or translation (5).
This, coupled to the fact that a function for Drosophila
mtTFB1 in mitochondrial translation has been documen-
ted (19), we next measured mitochondrial translation
rates in the h-mtTFB1 and h-mtTFB2 over-expression
HeLa cell lines using an in vivo-radiolabeling approach.
Similar to the analysis of the other mitochondrial gene
expression parameters (Figure 2), we again saw major
diﬀerences only in the h-mtTFB2 over-expression cell line,
where a signiﬁcant increase in the overall rate of
Table 1. Relative steady-state abundance of the mitochondrial transcription components in HeLa cells
Molecules/cell Molecules/
mtDNA
Molecules:
h-mtTFA
Molecules:
h-mtTFB1
Molecules:
h-mtTFB2
Molecules:POLRMT
h-mtTFA 2.52 10
5 4.86 10
4 50.3 8.8 – 18.6 3.59:1 5.87 1.13:1 8.07 1.56:1
h-mtTFB1 1.35 10
4 4.17 10
2 2.7 .08 1:18.6 3.59 – 1:3.17 .21 1:2.31 .15
h-mtTFB2 4.29 10
4 2.80 10
3 8.57 .56 1:5.87 1.13 3.17 21.1 – 1:37 .09:1
POLRMT 3.12 10
4 1.99 10
3 6.23 .39 1:8.07 1.56 2.31 15.1 1:1.37 .09 –
4048 Nucleic Acids Research, 2007, Vol. 35, No. 12translation was observed (Figure 3A). Interestingly,
however, the labeling of speciﬁc products was not uniform
(e.g. COX1, COX2 and ATP6), suggesting that increasing
the amount of h-mtTFB2 and/or mitochondrial mRNAs
is leading to increased translation of some mRNAs to the
exclusion of others.
Over-expression h-mtTFB1 increases sensitivity to the
aminoglycoside antibiotic kasugamycin
In all of the analyses described thus far, no obvious
consequences of over-expressing h-mtTFB1 alone
Figure 2. Over-expression of h-mtTFB2 increases the steady-state
levels of mtDNA-encoded transcripts and proteins, and doubles
mtDNA copy number. (A) Northern analysis of the mtDNA-
encoded 12S, 16S, ND2 and ND6 from the same cell lines
described in Figure 1B. Total RNA (2mg) from the indicated cell
line was loaded in each lane and the analysis was performed in
triplicate on samples from three independent cultures. Ethidium
bromide staining of the cytoplasmic 28S rRNA is shown as a
loading control. Results of a quantiﬁcation of the blots are graphed
below. The relative transcript level (ratio of the mitochondrial
signal to that of the 28S control) is plotted with the ratios obtained
in the h-mtTFB1 and h-mtTFB2 cell lines normalized to that
obtained from the empty-vector control cells, which was given a
value of 1. The values are the mean SD. (B) Western blot of
mitochondrial extracts from the indicated cell lines as in Figure 1B,
probed using antibodies that recognize the mtDNA-encoded COX1
and COX2 protein or porin (VDAC) as a loading control. This
demonstrates that there is an increase (on a per mitochondria basis)
of these components unlike h-mtTFA and POLRMT. (C) Plotted is
the relative mtDNA copy number (mtDNA relative to the nuclear
18S rDNA) normalized to that of the empty-vector control cells,
whose ratio was given a value if 1. The analysis was done in
triplicate and values shown are the mean SD.
Figure 3. Analysis of mitochondrial translation rates and kasugamycin
sensitivity in h-mtTFB1 and h-mtTFB2 over-expression HeLa cell
lines. (A) Mitochondrial translation products were labeled in vivo with
35S-methionine in the presence of the cytoplasmic translation inhibitor
emetine. Mitochondria were puriﬁed after labeling and 100mgo f
mitochondrial protein were loaded on a linear gradient polyacrylamide
gel. Shown on the left is a coomassie stain of the resulting gel
demonstrating equal protein loading and on the right is an
autoradiogram of the radiolabeled mitochondrial proteins (speciﬁc
proteins are indicated on the right). Changes in the proﬁle of labeled
products only occur during over-expression of h-mtTFB2. (B) Plotted is
the percent viable cells of the indicated cell lines after growth for 72h in
the indicated amount of the aminoglycoside kasugamycin. The analysis
was done in triplicate and values shown are the mean SD.
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expression of h-mtTFB1 did not inﬂuence mitochondrial
translation rates given that it is more active as a rRNA
methyltransferase (5) and that its Drosophila ortholog has
been implicated in translation eﬃciency (19). It remained a
formal possibility that h-mtTFB1 is aﬀecting mitochon-
drial ribosome function or biogenesis in manner that is not
read out as an increase in the overall rate of translation. In
bacteria, methylation of the small subunit rRNA by the
h-mtTFB1 ortholog KsgA results in sensitivity to the
aminoglycoside antibiotic kasugamycin and we have
shown that h-mtTFB1 and h-mtTFB2 can functionally
replace KsgA in E. coli (5). Furthermore, the human
mitochondrial 12S rRNA and the bacterial 16S rRNA are
highly conserved at the site that is methylated (a stem-loop
at the 30 end). We therefore determined whether over-
expression of h-mtTFB1 alters the sensitivity of human
mitochondrial ribosomes to kasugamycin. We found that
over-expression of h-mtTFB1 resulted in a signiﬁcant
decrease in viability of HeLa cells grown in the presence of
high concentrations of this drug (Figure 3B). Similar
results were obtained in the h-mTFB2 over-expression
line (Figure 3B). However, given that h-mtTFB1 is
also up-regulated when h-mtTFB2 is over-expressed
(Figure 1B), whether this eﬀect is due to h-mtTFB1 or
h-mtTFB2 or perhaps both cannot be distinguished.
Over-expression ofh-mtTFB1 or h-mtTFB2 increases
mitochondrial biogenesis, buttheir coordinate up-regulation
also results in increased membrane potential
Given that over-expression of h-mtTFB2 (and as a result
also h-mtTFB1, Figure 1B) results in an increase in
multiple mitochondrial gene expression parameters
(Figures 2 and 3), we next determined whether this
signaled cells to increase overall mitochondrial biogenesis.
In parallel, we also analyzed the h-mtTFB1 over-
expression line. Surprisingly, we found that both cell
lines exhibited a  50% increase in mitochondrial mass as
measured by Mitotracker Green staining and FACS
analysis (Figure 4A). Thus, despite the fact that over-
expression of h-mtTFB1 does not increase mitochondrial
gene expression in any manner examined thus far
(Figures 2 and 3), remarkably, it does invoke a
mitochondrial biogenesis response. The results of the
Mitotracker Green staining were largely conﬁrmed by
immunoblots, where mitochondrial biogenesis was
assayed as the ratio of the amount of the mitochondrial
outer membrane protein VDAC to that of tubulin
(Figure 4B). We also analyzed the h-mtTFB1 and
h-mtTFB2 over-expression cell lines for mitochondrial
membrane potential using Mitotracker Red staining and
FACS analysis. Here we observed an  80% increase in
membrane potential in the h-mtTFB2 over-expression
line, but no statistically signiﬁcant change as the result
of h-mtTFB1 over-expression alone (Figure 4A). These
results suggest the interesting possibility that the simulta-
neous up-regulation of both h-mtTFB1 and h-mtTFB2
(as is the case in the h-mtTFB2 over-expression lines) is
required to ﬁne-tune mitochondrial activity in accordance
with changes in mitochondrial biogenesis and gene
expression.
DISCUSSION
In this study, we have performed a detailed analysis of
the human mitochondrial transcription machinery in
HeLa cells. Speciﬁcally, we have determined for the
ﬁrst time the relative in vivo steady-state levels of the
four core components of this system: the human
mitochondrial RNA polymerase, POLRMT; the
mtDNA binding transcription factor, h-mtTFA; and the
two dual-function transcription factors/rRNA methyl-
transferases, h-mtTFB1 and mtTFB2. In addition, we
have clearly demonstrated that the two h-mtTFB paralogs
have unique attributes and distinct functions with regard
to mitochondrial gene expression and biogenesis. We will
discuss the primary ﬁndings and the main conclusion
we reach based on the results of this study below.
The ﬁrst goal of this study was to deﬁne the relative
amounts of the human mitochondrial transcription
machinery in vivo. Previously, groups have estimated the
amounts of h-mtTFA (6–8), but a simultaneous assess-
ment of the entire core transcription system had not been
described. We now have antibodies that recognize the four
core human mitochondrial transcription components and,
importantly, we generated peptide antibodies that are
capable of distinguishing the two related h-mtTFB
paralogs, h-mtTFB1 and h-mtTFB2 (Figure 1A). Using
these antibodies, we were able to detect each component in
mitochondrial extracts containing known amounts of total
mitochondrial protein by western blotting and compare
these to the signals obtained from known amounts of
cognate recombinant protein analyzed in parallel. Since
we also quantiﬁed the total number of cells from which the
extracts were derived and the copy number of mtDNA,
we are able to express the results for each individual
component as the number of molecules/cell or the number
of molecules/molecule of mtDNA (Table 1).
Our results revealed a number of novel and salient
points about the relative abundance of the mitochondrial
transcription system in HeLa cells (see Table 1). First,
relative to the mtDNA copy number, which we found to
be 5010 386 (Supplementary Figure S2), POLRMT is in
 6-fold excess of the mtDNA on a per-molecule basis. In
principle, this is suﬃcient to allow all templates to be
engaged in transcription simultaneously. The second main
conclusion that we reach is that there is roughly three
times more h-mtTFB2 than h-mtTFB1 molecules/cell.
This diﬀerence is perhaps most relevant when compared to
the amount of POLRMT, from which it becomes clear
that there is an excess of h-mtTFB2 to POLRMT (1.3:1),
but a limiting amount of h-mtTFB1 relative to POLRMT
(0.43:1). While the relevance of these diﬀerences is diﬃcult
to predict, it is noteworthy that for both h-mtTFB1 and
h-mtTFB2 the levels relative to POLRMT are not too far
removed from 1:1, which is consistent with the predicted
optimal stoichiometry in the core transcription complexes
for transcription in vitro (2). Finally, we arrive at a value
of  25000 molecules of h-mtTFA per cell, which places it
4050 Nucleic Acids Research, 2007, Vol. 35, No. 12in  5–18 fold excess of the other core transcription
components (Table 1).
Given that h-mtTFA has been postulated to have an
mtDNA-packaging role in addition to its transcription
factor function (7,31–34), its abundance relative to
mtDNA is important to discuss. Based on our measure-
ment of mtDNA copy number, the ratio of
h-mtTFA:mtDNA molecule we observe is 50 8:1.
This value is in good agreement with that of 35:1 reported
by Wiesner and colleagues (8), but substantially
lower than that proposed by Kang and colleagues, who
suggest a ratio of  1700:1 (7). Kang and colleagues
cite the ratio of mtTFA to mtDNA in Xenopus oocytes
at 2000:1 (9) to support of their ﬁndings (7). However,
ratios of X. laevis mtTFA (xl-mtTFA):mtDNA are greatly
up-regulated during Xenopus oocyte maturation ranging
from a resting immature oocyte level of  200:1 (35) to the
noted ratio of  2000:1 (9), which occurs only in mature
oocytes. Given that xl-mtTFA binds mtDNA as a
tetramer (36), there is eﬀectively  50 xl-mtTFA complexes
per genome in immature oocytes, which we argue is a
cell type that is more relevant for comparison to
mammalian cell types than a mature oocyte, which
has dramatically up-regulated mitochondria and
mtDNA in preparation for fertilization and development.
Finally, if h-mtTFA levels were indeed high enough
to completely coat the mtDNA genome as suggested
by Kang and colleagues (7,31,33,34), this would seem
incompatible with any signiﬁcant transcriptional output
based on in vitro transcription studies (2,37). Furthermore,
it becomes diﬃcult to explain why over-expression of
h-mtTFA increases mitochondrial transcription and
mtDNA copy number (32,38) if, in fact, mtDNA is
already fully saturated with h-mtTFA (31). It is note-
worthy that we observe less than one-sixth the amount
of h-mtTFA and ﬁve times more mtDNA per cell
than Takamatsu et al. measured in HeLa cells (7).
These diﬀerences likely begin to account for the apparent
overestimation of the mtTFA:mtDNA ratio by Kang
and colleagues compared to that reported herein and
by Wiesner and colleagues, which largely corroborate
each other.
Figure 4. Analysis of mitochondrial biogenesis and membrane potential in h-mtTFB1 and h-mtTFB2 over-expression HeLa cell lines. (A) Shown are
representative results from FACS analysis of the indicated cell lines (see key in ﬁgure) stained with Mitotracker Green FM, as a measure of
mitochondrial mass, or Mitotracker Red, as a measure of mitochondrial membrane potential. Plotted below is a quantiﬁcation of a triplicate analysis
of these parameters, with the mean ﬂuorescence of the vector control cell line given a value of 1. Error bars represent SD of three experiments and
asterisks indicate statistically signiﬁcant diﬀerences in mean ﬂuorescence as determined by t-tests,
  P50.005 and
   P50.0005. (B) Western blot of
whole-cell lysate (100mg protein) from empty-vector control, h-mtTFB1 over-expression, and h-mtTFB2 over-expression cell lines with antibodies
that recognize tubulin (a-tubulin) and a-porin (VDAC). The ratio of the VDAC signal to the tubulin signal is interpreted as a measure of the amount
of mitochondria per cell.
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human mitochondrial transcription system in HeLa cells,
we went on to analyze the consequences of over-expressing
each of the h-mtTFB paralogs on mitochondrial gene
expression and biogenesis in vivo. We established stable
HeLa cell lines that over-express h-mtTFB1 or h-mtTFB2
by  10-fold or up to  3-fold, respectively (Figure 1B).
Characterization of these lines by western blotting
immediately revealed a salient diﬀerence between these
two factors; that h-mtTFB2 is processed in vivo
(Figure 1B). Several additional lines of evidence strongly
indicate that the processing of h-mtTFB2 is via cleavage
by mitochondrial proteases upon import of the protein
into mitochondria, including a strong predicted mitochon-
drial protease cleavage site between amino acids 30 and
31, the presence of a predicted amphipathic alpha helix
(stereotypical of mitochondrial localization sequences)
spanning amino acids 5–22, and an inability to detect
h-mtTFB2 with a peptide antibody that was directed
against amino acids 2–20, which would be removed by the
predicted cleavage event (data not shown). No obvious
mobility diﬀerences were observed between recombinant
h-mtTFB1 and that isolated from cells. Furthermore,
SignalP does not predict a mitochondrial cleavage site
for h-mtTFB1 (data not shown). Thus, h-mtTFB2 and
h-mtTFB1 are handled quite diﬀerently upon import,
which is consistent with their distinct evolutionary history
subsequent to the putative gene duplication event that
created the two protein families early in eukaryotic lineage
(4,5). It is also tempting to speculate that the use of
diﬀerent modes of import for these two transcription
factors could provide a mechanism to control their relative
levels in the organelle in response to diﬀerent conditions.
A second important observation that came from the
initial analysis of the h-mtTFB1 and h-mtTFB2 over-
expression lines is that there is an increase in h-mtTFB1
when h-mtTFB2 is over-expressed (Figure 1B). However,
the converse was not true. That is, in the h-mtTFB1 over-
expression line, there is no change in the steady-state
amounts of h-mtTFB2 per mitochondrion (Figure 1B).
Furthermore, there are no obvious changes in the levels of
POLRMT or h-mtTFA per mitochondrion in either of the
h-mtTFB factor over-expression lines (Figure 1D). We
conclude that there is some form of one-way communica-
tion between h-mtTFB2 and h-mtTFB1. The fact that this
upregulation occurs, at least in part, via increased levels of
the h-mtTFB1 mRNA (Figure 1C), suggests that this
involved a retrograde signal transduction mechanism from
the mitochondria to the nucleus (39). It is tempting to
speculate that this response is initiated via signals
generated by alterations in mitochondrial transcriptional
output or the amount of 12S rRNA methylation.
We next examined multiple mitochondrial parameters
in the h-mtTFB1 and h-mtTFB2 over-expression cell lines.
In the h-mtTFB2 over-expression cell lines (where it is
important to keep in mind that there is also a compensa-
tory increase in mtTFB1 as discussed above; Figure 1B),
there is a  2-fold increase in overall mitochondrial
transcript levels as evidenced by northern analysis of the
two rRNAs (12S and 16S) and two mRNAs (ND2 and
ND6) encoded by mtDNA and representing transcripts
derived from both strands (Figure 2A). This was
accompanied by a corresponding doubling of the
mtDNA copy number (Figure 2C). Given the documented
roles for the h-mtTFB factors in directing transcription
initiation eﬃciency (2), these changes most likely represent
an increase in the rate of mitochondrial transcription that
is also driving a increase in transcription-primed mtDNA
replication (1). However, it remains a formal possibility
that the increase in steady-state levels of mitochondrial
transcripts is due to enhanced RNA stability and/or
similar rates of transcription from the increased number of
mtDNA templates. Also evident in the h-mtTFB2 over-
expression lines was an increased rate of mitochondrial
translation of most, but not all mitochondrial gene
products (Figure 3A) that, at least in the case of COX1
and COX2, results in signiﬁcantly increased steady-state
amounts of protein (Figure 2B). However, the rates of
mitochondrial translation were not uniform for all of the
subunits. For example, there is apparently a reduced rate
of translation of ATP6 and no apparent change in the rate
of synthesis of ND3 or ND4L (Figure 3A). Thus,
artiﬁcially raising the levels of h-mtTFB2 (and in response,
also h-mtTFB1) does increase mitochondrial gene expres-
sion and mtDNA replication, but may come at the cost of
imbalanced relative rates of mitochondrial protein synth-
esis. We suspect that most of the described eﬀects on
mitochondrial gene expression just listed are driven
primarily by the increased levels of h-mtTFB2 since no
major changes in mtDNA copy number, transcript levels,
translation rates or steady-state levels of COX1 and COX
2 were observed in the cell line in which h-mtTFB1 alone
was over-expressed (Figures 2 and 3). However, it is also
just as likely that up-regulation of both factors is
necessary to coordinately mount all of the responses we
observe.
The lack of a signiﬁcant ‘mitochondrial gene expression’
response in the h-mtTFB1 over-expression lines is some-
what surprising given the documented ability of this
protein to activate transcription in vitro (2,3). One
potential reason for this may be explained via the relative
levels of the transcription system we established in these
cells. For example, the ratio of h-mtTFA to h-mtTFB1
required for optimal transcription in vitro is  1:2 (2).
Thus, the corresponding ratio we determined in vivo of
18:1 would likely not allow much of a contribution of h-
mtTFB1 to the total transcriptional output. Furthermore,
to reach the optimal ratio of 1:2 would require nearly 40-
fold over-expression of h-mtTFB1. We were only able to
increase h-mtTFB1 by  10-fold, which likely explains why
no alterations in mitochondrial transcripts were observed
in the h-mtTFB1 over-expression cell lines (Figure 2A). In
contrast, the ratio of h-mtTFA to h-mtTFB2 in vivo of 5:1
(Table 1) is well within the range of 2:1–40:1 that is
optimal for mitochondrial transcription in vitro (2).
Increasing this by  3-fold in the h-mtTFB2 over-
expression cell line would keep this ratio within this
optimal range, entirely consistent with our results.
Whether the relative amounts of the transcription
components vary in diﬀerent cell or tissue types
such that h-mtTFB1 also contributes to mitochondrial
transcription remains an open question.
4052 Nucleic Acids Research, 2007, Vol. 35, No. 12While over-expression of h-mtTFB1 does not show any
major eﬀects on the mitochondrial transcription and
translation parameters we measured, it did result in
increased sensitivity of HeLa cells to the aminoglycoside
antibiotic kasugamycin (Figure 3B). Sensitivity to this
antibiotic in E. coli is modulated by dimethylation of
two adenine residues in the 30 terminal stem loop of the
small subunit ribosomal RNA by KsgA (40,41), the
bacterial homolog of h-mtTFB1 and h-mtTFB2. We have
shown previously that h-mtTFB1 and h-mtTFB2 are able
to methylate the homologous stem-loop in bacteria and
restore sensitivity to kasugamycin (5,14). Thus, we
interpret the ability of increased levels of h-mtTFB1
to sensitize HeLa cells to kasugamycin to indicate that
h-mtTFB1 is increasing the number of methylated
ribosomes that are targets for inhibition by the drug.
This provides the ﬁrst in vivo conﬁrmation that h-mtTFB1
is likely the 12S rRNA methyltransferase in human
mitochondria as we predicted from our earlier studies
(5,14). Interestingly, we observed a similar sensitivity to
kasugamycin in the h-mtTFB2 over-expression lines
(Figure 3B). While this is most likely due to the fact that
h-mtTFB1 is also up-regulated in this cell line, we cannot
exclude the possibility that h-mtTFB2 is also contributing
to the methylation of the 12S rRNA since it too possesses
rRNA methyltransferase activity, albeit at a much lower
level (5). In this regard it is interesting to note that others
have shown that diﬀerent methylation combinations on
the E. coli 16S rRNA (adenines in the stem loop being
monomethylated, dimethylated or mixed) result in diﬀer-
ent levels of aminoglycoside resistance (10). Thus, the idea
that h-mtTFB1 and h-mtTFB2 might orchestrate diﬀerent
states of 12S rRNA methylation with diﬀerent functional
outcomes is an intriguing possibility.
Finally, we have elucidated a new role for h-mtTFB1
and h-mtTFB2 in mitochondrial biogenesis. Over-
expression of h-mtTFB1 alone results in a  50% increase
in mitochondrial membrane as judged by Mitotracker
Green staining and conﬁrmed by western analysis of
a mitochondrial marker protein, porin (a.k.a. VDAC,
Figure 4). Thus, even in the absence of a direct eﬀect on
mitochondrial transcription or translation, increased
h-mtTFB1 somehow signals a change in mitochondrial
biogenesis. It will be of interest to determine the nature of
this signal and whether it involves, for example, a sensing
of the amount of ongoing mitochondrial ribosome
assembly through the rRNA methylation status. A similar
increase in mitochondrial biogenesis is observed in the
h-mtTFB2 over-expression cell line (Figure 4), in
which both h-mtTFB1 and h-mtTFB2 are elevated.
However, here, unlike h-mtTFB1 over-expression alone,
it was accompanied by a signiﬁcant ( 80%) increase
in mitochondrial membrane potential (Figure 4A).
Taken together, these results suggest that, while
h-mtTFB1 can alone induce a mitochondrial biogenesis
response, an increase in both h-mtTFB1 and h-mtTFB2 is
needed to coordinate an increase in mitochondrial gene
expression with the increase in mitochondrial mass. We
propose that the lack of an increase in membrane potential
in the h-mtTFB1 over-expression cell line (Figure 4A) is a
result of a defect in this response that leads to more
mitochondria with fewer OXPHOS complexes per mass of
organelle.
This study provides the ﬁrst analysis of the relative
levels of the human mitochondrial transcription system
and functional roles of the h-mtTFB1 and h-mtTFB2
paralogs in vivo. Our results revealed distinct, but possibly
coordinated functions of each of these factors in
mitochondrial gene expression, biogenesis and activity
that provide a new framework for future studies aimed at
understanding the regulation of human mitochondrial
transcription system in vivo and its potential as a
therapeutic target for human diseases and aging.
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